Israel Active

The US FDA has granted marketing authorization to the PMD-200 monitor developed by Israel’s Medasense Biometrics (see previously). The device monitors pain in non-communicating (e.g., anaesthetized) patients and already has made an impact in multiple countries.

Israel’s Protai has built a proteomics AI-based platform that comprehensively maps the course of a disease on the protein level. It can identify which patients will respond to a given treatment, as well as identifying identify diseases that a therapy should be able to treat.

Delray Medical Center is the first hospital in Florida to treat an Alzheimer’s disease patient using non-invasive focused ultrasound technology from Israel’s Insightec. The FDA-approved clinical trial will test reducing excessive protein buildup to open the blood-brain barrier.

Israel’s LDS Biotech has developed the Lyotropic treatment delivery system. Medications can be applied directly to the problem area without causing damage to organs such as the liver. It was successful in compassionate use and clinical (human) trials are being planned.

Researchers at Israel’s Ben-Gurion University found a new approach for treating Alzheimer’s disease. They developed a new molecule VBIT-4 that prevents the over-expression of the protein VDAC1, which controls mitochondrial activity and cell life and death.

Israel’s SenterCare claims to have the only unobstructive technology that can differentiate between people in the same home. It notifies about safety incidents, with AI to predict falls and recommend interventions. Its aim is to preserve and prolong the senior’s quality of life and reduce health costs.

Several Israeli startups are involved in helping people to live longer. Longevity.AI has developed a comprehensive system for hospitals, health funds, and other medical organizations that allows them to track and monitor the health of their patients in real-time. It says it is never too early to grow younger.

Israel’s AEYE Health (see previously) is trialing its AI-based retinal camera on 500 patients at UMass (University of Massachusetts Amhurst) medical school. The camera detects retinopathy (eye disease) and is operated by a family doctor or nurse, without the need for an eye specialist.

Israel’s Grin is literally changing the face of dental visits.  Why waste time with a face-to-face appointment with your dentist or orthodontist when they just want to see your teeth. Sign up; send off for the Grin Scope; download the Grin App; scan your teeth; and schedule a virtual meeting with your dentist.

AION Labs, the Israeli innovation lab for startups (see previously), has helped launch DenovAI – a startup that will harness artificial intelligence and biophysics to build a platform for computer-designed antibodies from the start, geared to the development of new treatments.